| Patents for C07H 15 - Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals (17,975) |
|---|
| 06/06/2002 | WO2002044191A2 Anti-inflammatory compounds derived from pseudopterogorgia elisabethae |
| 06/06/2002 | WO2002044190A2 PROCESSES FOR THE PREPARATION OF αGal(1→3)βGal(1→4)Glc-OR |
| 06/06/2002 | WO2002043678A2 Enzymatic fixation of derivatised carbohydrates to fibrous materials |
| 06/06/2002 | WO2001090129A3 Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with mono and disaccharide-base compounds |
| 06/06/2002 | WO2001079242A3 Process for preparing lipid ii and derivatives thereof |
| 06/06/2002 | US20020068331 Production of fucosylated carbohydrates by enzymatic fucosylation synthesis of sugar nucleotides; and in situ regeneration of GDP-fucose |
| 06/06/2002 | DE10040381C1 Perfluoralkylhaltige Komplexe mit Zuckerresten, Verfahren zu deren Herstellung und ihre Verwendung Perfluoroalkyl-containing complexes with sugar residues, processes for their preparation and their use |
| 06/06/2002 | CA2430398A1 Anti-inflammatory compounds derived from pseudopterogorgia elisabethae |
| 06/06/2002 | CA2429833A1 Glucopyranosyloxybenzylbenzene derivatives, medicinal compositions containing the same and intermediates in the production thereof |
| 06/05/2002 | EP1211320A2 Methods and compositions for synthesis of oligosacccharides using mutant glycosidase enzymes |
| 06/05/2002 | EP1211258A1 Process for preparing solubilizing adjuvants from fusel oils and oses |
| 06/05/2002 | EP1210355A2 Glycoconjugates, glycoamino, acids, intermediates thereto, and uses thereof |
| 06/05/2002 | EP1210354A1 Prodrugs for liver specific drug delivery |
| 06/05/2002 | EP1080115B1 Complexes for immobilising isothiocyanate natural precursors in cyclodextrins, preparation and use |
| 06/05/2002 | CN1085980C Meta-guanidine, urea, thiourea or azacyclic amino benzoic and derivatives as integrin antagaonists |
| 06/04/2002 | US6399583 Hybrid anthracyclines from genetically engineered streptomyces galilaeus strains, process for production and uses thereof |
| 06/04/2002 | US6399578 Conjugates comprising galactose α1,3 galactosyl epitopes and methods of using same |
| 06/04/2002 | US6399071 Removal of xenobodies from body fluid |
| 06/04/2002 | CA2014459C Targeted forms of methyltrithio antitumor agents |
| 05/30/2002 | WO2002028875A3 Improved synthesis of purine locked nucleic acid analogues |
| 05/29/2002 | EP1208844A1 Therapeutic agent for mastitis of livestock and method for treating mastitis using the same agent |
| 05/29/2002 | EP0790991B1 Novel 1,2-dioxetane compounds with haloalkoxy groups, methods of preparation and use |
| 05/29/2002 | CN1085674C Safflower total uranidin, its preparation and application |
| 05/28/2002 | US6395893 Crystallization of lactitol, crystalline lactitol product and use thereof |
| 05/28/2002 | US6395886 Anticancer agents |
| 05/28/2002 | US6395266 Terminally-branched polymeric linkers and polymeric conjugates containing the same |
| 05/28/2002 | US6395257 Administering indocyanine dye of specific structure to individual for diagnostic imaging or antitumor therapy |
| 05/23/2002 | WO2002040496A1 Process for the synthesis of optically active anthracyclines |
| 05/23/2002 | WO2002039832A1 Use of lactitol for improving intestinal microflora |
| 05/23/2002 | WO2001042179A9 Compounds which mimic the chemical and biological properties of discodermolide |
| 05/23/2002 | US20020061300 Method and composition for treating prostate cancer |
| 05/22/2002 | EP1207391A1 Method for screening targeting dds preparation |
| 05/22/2002 | EP1207164A2 Method for producing a powder containing crystalline maltitol particles |
| 05/22/2002 | EP0944640B1 Use of a crystallisation-inhibiting additive for surface-active nonionic glycosides |
| 05/22/2002 | EP0888371B1 4,7-dialkoxy-n-acetylneuraminic acid derivatives and methods for detection of influenza type a and b viruses in clinical specimens |
| 05/22/2002 | EP0828747B1 Process for preparing alkyloligoglucosides with a high degree of oligomerization |
| 05/22/2002 | EP0827506A4 Synthesis of glycopolymers |
| 05/22/2002 | EP0606317B1 Saponin-antigen conjugates and the use thereof |
| 05/22/2002 | CN1350512A Method of preparing surface-active alcohols and surface-active alcoholic ethers, products obtained by said method and their use |
| 05/22/2002 | CN1349998A Simple synthesis of galactose 3,6 places branching oligose |
| 05/22/2002 | CN1349997A Stevioside glycoside refining process |
| 05/21/2002 | US6391913 Derivatives of paclitaxel, method for producing same and uses thereof |
| 05/21/2002 | US6391863 Use of carbohydrates for promoting skin desquamation |
| 05/16/2002 | WO2002038530A1 Carboxylic acid type lipid |
| 05/16/2002 | WO2002038187A1 Fap-activated anti-tumour prodrug |
| 05/16/2002 | WO2001070663A3 Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors |
| 05/16/2002 | WO2001066100A3 Pharmaceutical composition |
| 05/16/2002 | US20020058804 Includes an active therapeutic agent joined to a blocking moiety sensitive to the catalytic action of molecules having retro- aldol and retro-Michael catalytic activity; antitumor; anticarcinogenic agents |
| 05/16/2002 | US20020058795 Preferential particles for use in the transfer of macromolecules into cells; for use in gene therapy |
| 05/16/2002 | US20020058635 Purine L-nucleosides, analogs and uses thereof |
| 05/16/2002 | US20020058288 Compound for use in the detection and prevention of parasitic infection of humans |
| 05/16/2002 | US20020058067 Solid drug delivery system |
| 05/16/2002 | US20020058062 At least 13% glucoside isoflavones and 0.6-1.5 parts 3 soya saponins per 1 part by weight of glucoside isoflavones; treating pre or post menopausal symptoms, breast and prostate cancer, and alcoholism |
| 05/16/2002 | CA2326043A1 Functionalised silicon surfaces, and method for their production |
| 05/15/2002 | EP1205558A1 Process for producing glycosides |
| 05/15/2002 | EP1204643A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 05/15/2002 | EP0880538B1 Method for preparing surface-active agents |
| 05/15/2002 | EP0688329B1 Novel phospholipid-saccharide conjugates |
| 05/15/2002 | CN1084623C Special alpha-glactonic neuroamide, pharmaceutical composition and its use |
| 05/14/2002 | US6388103 Preparation method of arbutin intermediates |
| 05/14/2002 | US6388059 Contacting glycoside having anomeric sulfoside with compound having free hydroxyl in presence of organic acid anhydride and alkene to scavenge sulfenyl esters; increased yield with reduced by-product formation |
| 05/14/2002 | US6388058 Method of purifying daunomycin |
| 05/14/2002 | US6387961 Alkyl 2-acetamido-2-deoxyglucopyranoside and methods of emulsifying |
| 05/14/2002 | US6387944 Benzo(b)thiepine-1,1-dioxide derivatives, a method for the production thereof, medicaments containing these compounds, and their use |
| 05/14/2002 | US6387943 Vancoresmycin, a process for its production and its use as a pharmaceutical |
| 05/10/2002 | WO2001036433A3 Synthetic lipid-a analogs and uses thereof |
| 05/10/2002 | WO2001003681A3 Use of flavones, coumarins and related compounds to treat infections |
| 05/08/2002 | EP1203002A1 Process for preparing a charcoal-gm1 complex |
| 05/08/2002 | EP1202718A2 Substituted guanidines for the treatment of cancer and pain |
| 05/08/2002 | CN1348498A Novel Nucleic acid transferring agents, compsoitions containing them and uses |
| 05/08/2002 | CN1348460A Acetal Benzylmaltosides as inhibitors of smooth muscle cell proliferation |
| 05/07/2002 | US6383812 Solid phase synthesis of peptide |
| 05/05/2002 | WO2002042270A1 Substituted benzene derivatives or salts thereof |
| 05/02/2002 | WO2002034932A1 A process of preparing a derivatised saccharide |
| 05/02/2002 | WO2002034761A1 Pyranoside derivatives |
| 05/02/2002 | US20020052526 Antimicrobial 2-deoxystreptamine compounds |
| 05/02/2002 | US20020052327 Novel sulfoquinovosylacylglycerol derivative, and use thereof as medicaments |
| 05/02/2002 | US20020052326 Treating diabetes and related diseases in combination with one, two or more other antidiabetic agents and/or one, two or more hypolipidemic agents. |
| 05/02/2002 | US20020051881 Hollow fibrous organic nanotube and method for producing the same |
| 05/02/2002 | US20020051799 Glucosylated hydroxystilbene compounds for treating skin conditions |
| 05/02/2002 | EP1200441A1 Process for making morphine-6-glucuronide and its analogues using haloglucuronate ester intermediates |
| 05/02/2002 | EP1200131A2 Compositions and methods for targeted enzymatic release of cell regulatory compounds |
| 05/02/2002 | EP0931086B1 Tetrahydronaphthalene derivatives and their therapeutic use |
| 05/02/2002 | EP0765336B1 Synthesis of conduritol epoxides and aziridines and methods of using such to synthesize higher disaccharides |
| 05/02/2002 | DE10052658A1 Neue Pyranosidderivate New Pyranosidderivate |
| 05/02/2002 | CA2426564A1 Pyranoside derivatives |
| 05/01/2002 | CN1347323A Chemical compounds |
| 05/01/2002 | CN1347322A Chemical compounds |
| 05/01/2002 | CN1083886C Oligosaccharide amino alditols and assay method |
| 04/30/2002 | US6380403 Illudin analogs useful as antitumor agents |
| 04/30/2002 | US6380379 Derivatized reduced malto-oligosaccharides |
| 04/25/2002 | WO2002032963A1 Immunoadjuvant systems |
| 04/25/2002 | WO2002032915A1 Combinatorial libraries of monosaccharides |
| 04/25/2002 | WO2002032860A2 Dynamic organ function monitoring agents |
| 04/25/2002 | WO2002032465A1 Tissue-specific exogenous optical agents |
| 04/25/2002 | US20020049183 Phospholipids, espeically phosphatidylethanolamines, covalently bound to physiologically acceptable monomers or polymers. |
| 04/25/2002 | US20020049171 Methods of and compositions for potentiating the action of agents active on cell wall sites of the susceptible bacteria |
| 04/25/2002 | US20020049163 Nucleosidic and non-nucleosidic folate conjugates |
| 04/25/2002 | US20020048588 Augment antibody production in immunized animals as well as stimulate cytokine production and activate macrophages. |
| 04/25/2002 | CA2425718A1 Dynamic organ function monitoring agents |